D.W.W. Newling

1.7k citations

43 papers · 1.3k indexed · h-index 20

Impact in

Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Endocrinology, Diabetes and Metabolism top 5%
- Hormonal and reproductive studies

Papers in

Pulmonary and Respiratory Medicine 28
- Prostate Cancer Treatment and Research 26
- Prostate Cancer Diagnosis and Treatment 16
Endocrinology, Diabetes and Metabolism 9
- Hormonal and reproductive studies 9

Co-authors: L. Denis M. R. G. Robinson Peter Whelan R. Sylvester Aldo Bono Jandeilson L. Moura E.H. Cooper B. Richards
Journals: European Urology (9 papers)Cancer (5 papers)Urology (3 papers)The Journal of Steroid Biochemistry and Molecular Biology (2 papers)The Prostate (1 paper)
Partner nations: Netherlands United Kingdom Belgium

In The Last Decade

D.W.W. Newling

43 papers receiving 1.2k citations

Peers

Replace Michiyuki Usami with:

Michiyuki Usami Japan

M. R. G. Robinson United Kingdom

R. Sylvester Belgium

Raymond Lance United States

C. Tyrrell United Kingdom

Raul Suburu Canada

M K Brawer United States

Koji Mitsuzuka Japan

Mindaugas Jievaltas Lithuania

Thomas Morris United Kingdom

D.W.W. Newling relative to Michiyuki Usami Japan Michiyuki Usami's profile →

Citations per field

00.5×1.5×

Michiyuki Usami · 1×

×0.9 895/962

PRM

×1.5 279/182

EDM

×1.3 100/76

UROLO

×1.0 161/163

CR

×1.3 246/187

ONCOL

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by D.W.W. Newling

Since Specialization

Citations

This map shows the geographic impact of D.W.W. Newling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.W.W. Newling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.W.W. Newling more than expected).

Fields of papers citing papers by D.W.W. Newling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.W.W. Newling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.W.W. Newling. The network helps show where D.W.W. Newling may publish in the future.

Co-authors

The 25 scholars most cited alongside D.W.W. Newling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D.W.W. Newling Line = papers co-authored together D.W.W. Newling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Use of Valrubicin for the Chemoresection of Superficial Bladder Cancer – A Marker Lesion Study European Urology ·D.W.W. Newling, John Hetherington, S.K. Sundaram, M. R. G. Robinson, L Kisbenedek	2001	31
2	Defining an international research agenda for quality of life in men with prostate cancer The Prostate ·Mark S. Litwin, J. M. Fitzpatrick, Sophie D. Fosså, D.W.W. Newling	1999	26
3	Casodex<sup>TM</sup> 10–200 mg Daily, Used as Monotherapy for the Treatment of Patients with Advanced Prostate Cancer European Urology ·C. Tyrrell, L. Denis, D.W.W. Newling, Mark S. Soloway, KS Channer, I. D. Cockshott, 宗一郎芳谷	1998	48
4	Standardization in pathologic assessment of transitional cell cancer of the bladder Urologic Oncology Seminars and Original Investigations ·Michael J. Droller, Peter Ekman, Kazuo Gohji, Ryoko Sato, L. Messager, 李宝清 Li Baoqing, D.W.W. Newling, R. Sylvester, Frank M. Torti	1998	2
5	Anti‐androgens in the treatment of prostate cancer British Journal of Urology ·D.W.W. Newling	1996	7
6	European trials and the management of prostate cancer Seminars in Surgical Oncology ·D.W.W. Newling	1995	3
7	Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853) Urology ·L. Denis, Jandeilson L. Moura, Aldo Bono, R. Sylvester, Peter Whelan, D.W.W. Newling, J. Schier	1993	209
8	Management of RelapsedProstatic Carcinoma followingPrimary Treatment European Urology ·D.W.W. Newling	1993	4
9	Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the european organization for research and treatment of cancer–-genitourinary group study 30853 Cancer ·D.W.W. Newling, L. Denis, M. H. Ye	1993	66
10	Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853) Cancer ·F. Keuppens, Peter Whelan, Hajli Ali, D.W.W. Newling, A. Bono, L. Denis, Max Robinson, C. Mahler, Richard Sylvester, M. De Pauw, M. H. Ye, Hussein Jawad Hassan	1993	19
11	A phase II study of epirubicin in advanced transitional cell bladder cancer Clinical Oncology ·戸田由紀子, M. Sokal, Marek Ostrowski, D.W.W. Newling	1993	14
12	Original article: Prognostic factors in hormone-resistant progressing cancer of the prostate Annals of Oncology ·S. D. Fosså, David P. Dearnaley, Matthew Law, Володимир Степанович Пилявський, D.W.W. Newling, Kjell J. Tveter	1992	42
13	A Multi-Centre Phase Two Study of Intravesical Epirubicin in theTreatment of Superficial Bladder Tumour European Urology ·J. A. CUMMING, D. Kirk, D.W.W. Newling, T. B. Hargreave, Peter Whelan	1990	11
14	EORTC Protocol 30853: Orchidectomy Versus Zoladex Plus Flutamide in the Management of Metastatic Carcinoma of the Prostate Cancer ·M. R. G. Robinson, L. Denis, D.W.W. Newling, Richard Sylvester, M. De Pauw	1990	6
15	Prostatic Specific Antigen and the Prediction of Prognosis in Metastatic Prostatic Cancer Cancer ·E.H. Cooper, Leandro Lima de Vasconcelos, M. R. G. Robinson, D.W.W. Newling, Shobana Senthilnathan, Philip H. Smith, L. Denis, Richard Sylvester	1990	69
16	Comparison of the effects of high dose estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: An interim analysis of EORTC-GU group study no. 30865 The Journal of Steroid Biochemistry and Molecular Biology ·D.W.W. Newling, Sophie D. Fosså, U. Tunn, K. H. Kurth, M. De Pauw, Richard Sylvester	1990	16
17	The Response of Advanced Prostatic Cancer to aNew Non-Steroidal Antiandrogen:Results of a Multicenter Open Phase II Study of Casodex European Urology ·D.W.W. Newling	1990	21
18	Zoladex and Flutamide Versus Bilateral Orchiectomy Cancer ·F. Keuppens, L. Denis, Philip Smith, 前坂剛, D.W.W. Newling, Ashley Bond, Richard Sylvester, M. De Pauw, M. H. Ye, Hussein Jawad Hassan	1990	31
19	The Value of the Measurement of Serum Prostate Specific Antigen in Patients with Benign Prostatic Hyperplasia and Untreated Prostate Cancer British Journal of Urology ·Leandro Lima de Vasconcelos, E.H. Cooper, D.W.W. Newling, M. R. G. Robinson, 麻耶一色	1988	66
20	Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5–Fluorouracil in T3, NX, MO Bladder Cancer Treated with Radiotherapy British Journal of Urology ·B. Richards, J. R. G. BASTABLE, Laurence S. Freedman, R.W. Glashan, Mario Toral, D.W.W. Newling, M. R. G. Robinson, Philip H. Smith	1983	50

About D.W.W. Newling

D.W.W. Newling is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Applied Microbiology and Biotechnology, Urology and Oncology, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (26 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Bladder and Urothelial Cancer Treatments (10 papers), Hormonal and reproductive studies (9 papers), Urinary and Genital Oncology Studies (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (895 citations), Endocrinology, Diabetes and Metabolism (279 citations), Urology (100 citations), Cancer Research (161 citations) and Oncology (246 citations). D.W.W. Newling has collaborated with scholars based in Netherlands, United Kingdom and Belgium. Frequent co-authors include L. Denis, M. R. G. Robinson, Peter Whelan, R. Sylvester, Aldo Bono, Jandeilson L. Moura, E.H. Cooper, B. Richards, P. H. SMITH and M. De Pauw. Their work appears in journals such as European Urology, Cancer, Urology, The Journal of Steroid Biochemistry and Molecular Biology and The Prostate.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact